Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds.
The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Promoting Pluripotency: A specialized mammalian cell can be set back to the pluripotent state either by transfer of the somatic cell nucleus into an oocyte or by delivery of exogenous pluripotency-associated transcription factors. Hou et al. (p. 651 , published online 18 July) developed an approach to induce pluripotency in somatic cells using a cocktail of small molecules. The ability to generate such chemically induced pluripotent stem cells may provide an alternate route for therapeutic cloning and for drug development in regenerative medicine.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Developing a chemical alternative to mimic OSK’s rejuvenating effects could lower costs and shorten timelines in regenerative medicine development [26, 28–31].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [31]
In the citing paper
“Recent studies have demonstrated the potential of small molecule stimulation in facilitating chemical reprogramming by inducing an intermediate plastic state [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“Notably, specific small molecules such as 3-deazaneplanocin A, 5-azacytidine, sodium butyrate and RG108 have emerged as potential epigenetic modifiers 72 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
In the citing paper
“These small molecules effectively target key signaling pathways involved in cellular reprogramming, benefiting both human and mouse somatic cells [71][72][73] .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [72]
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells
Boyer, L. A., Lee, T. I., Cole, M. F., Johnstone, S. E., Levine, S. S., Zucker, J. P., Guenther, M. G., Kumar, R. M., Murray, H. L., Jenner, R. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.020 · Cited by 4,505
The ground state of embryonic stem cell self-renewal
Ying, Q.-L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., Cohen, P., & Smith, A. (2008) · Nature · doi:10.1038/nature06968 · Cited by 3,442
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Self-citationSamavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.-K., Beyer, T. A., Datti, A., Woltjen, K., Nagy, A., & Wrana, J. L. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.015 · Cited by 943
Chazaud, C., Yamanaka, Y., Pawson, T., & Rossant, J. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.02.020 · Cited by 898
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895
Induced pluripotency: history, mechanisms, and applications
Stadtfeld, M., & Hochedlinger, K. (2010) · Genes & Development · doi:10.1101/gad.1963910 · Cited by 829
Promotion of Reprogramming to Ground State Pluripotency by Signal Inhibition
Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J., Theunissen, T. W., & Smith, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060253 · Cited by 818
Cited by
Items 801–900 of 1,005
AP-1 activity is a major barrier of human somatic cell reprogramming
Liu, Y., He, J., Chen, R., Liu, H., Chen, J., Liu, Y., Wang, B., Guo, L., Pei, D., Wang, J., et al. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03883-x · Cited by 10
Induced Pluripotency for Translational Research
Wu, M., Chen, G., & Hu, B. (2013) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2013.08.001 · Cited by 10
Ye, B., Yang, L., Liu, B., Liu, N., Fan, D., Li, H., Sun, L., Du, Y., Wang, S., Tian, Y., et al. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00842-9 · Cited by 10
Self-citationZheng, M., Xie, B., Okawa, S., Liew, S. Y., Deng, H., & del Sol, A. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.10.013 · Cited by 10
Self-citationSun, L., Zhang, D., Qin, L., Liu, Q., Wang, G., Shi, D., & Huang, B. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1020965 · Cited by 10
Bao, Q., Tay, N. L., Lim, C. Y., Chua, D. H. H., Kee, S. K., Choolani, M. A., Loh, Y., Ng, S. C., & Chai, C. (2024) · Scientific Reports · doi:10.1038/s41598-023-50510-9 · Cited by 10
Bovine Pluripotent Stem Cells: Current Status and Prospects
Chen, L., Tang, B., Xie, G., Yang, R., Zhang, B., Wang, Y., Zhang, Y., Jiang, D., & Zhang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042120 · Cited by 10
Self-citationZhang, K., Wang, Y., An, Q., Ji, H., Wu, D., Li, X., Suo, L., Zhang, C., & Dong, X. (2024) · Cell Proliferation · doi:10.1111/cpr.13785 · Cited by 10
Cell and tissue reprogramming: Unlocking a new era in medical drug discovery
Sen, C. K., Friday, A. J., & Roy, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100077 · Cited by 11
Pan, C., Jia, W., Lu, B., & Bishop, C. E. (2014) · Gene · doi:10.1016/j.gene.2014.11.061 · Cited by 10
Zare, L., Baharvand, H., & Javan, M. (2019) · PubMed Central · Cited by 10
Primitive Cancer Cell States: A Target for Drug Screening?
Wan, A. C. A. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.01.003 · Cited by 10
Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments
Zhang, X., Li, Z., Liu, Y., & Gai, Z. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51842 · Cited by 10
Self-citationReisqs, J., Moreau, A., Sleiman, Y., Boutjdir, M., Richard, S., & Chevalier, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1191965 · Cited by 10
Derivation of elephant induced pluripotent stem cells
Appleton, E., Korover, N., Hong, K.-H., Ambriz-Peña, X., Tanaka, Y., Ashkenazy-Titelman, A., Rasmussen-Ivey, C. R., Rodríguez-Caycedo, C., Bhide, K. P., Bai, H., et al. (2026) · Nature Methods · doi:10.1038/s41592-026-03136-4 · Cited by 10
Targeting components of epigenome by small molecules
You, J. S., & Han, J. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0455-9 · Cited by 10
Stem Cells for Osteodegenerative Diseases: Current Studies and Future Outlook
Descalzo, D. L. M., Ehnes, D. D., & Nieden, N. I. Z. (2014) · Regenerative Medicine · doi:10.2217/rme.13.100 · Cited by 10
Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health
Donadeu, F. X., & Esteves, C. L. (2015) · Frontiers in Veterinary Science · doi:10.3389/fvets.2015.00059 · Cited by 10
From stem cells to red blood cells: how far away from the clinical application?
Xie, X., Li, Y., & Pei, X. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4667-5 · Cited by 10
Self-citationInduced Pluripotent Stem Cells in Regenerative Medicine
Pane, L. S., My, I., & Moretti, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-27610-6_3 · Cited by 10
Chemicals as the Sole Transformers of Cell Fate
Ebrahimi, B. (2016) · International Journal of Stem Cells · doi:10.15283/ijsc.2016.9.1.9 · Cited by 10
Kramer, N., Rosner, M., Kovačic, B., & Hengstschläger, M. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1763-2 · Cited by 10
Lu, B., & Atala, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802225-2.00006-4 · Cited by 10
Phenotype and target-based chemical biology investigations in cancers
Chen, G., Xu, Y., Shen, S.-M., & Zhang, J. (2018) · National Science Review · doi:10.1093/nsr/nwy124 · Cited by 10
Ryu, J., Hwang, N. S.-Y., Park, H. H., & Park, T. H. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105717 · Cited by 10
Cui, G., Xu, Y., Cao, S., & Shi, K. (2022) · Molecular Reproduction and Development · doi:10.1002/mrd.23559 · Cited by 10
MEK and TGF-beta Inhibition Promotes Reprogramming without the Use of Transcription Factor
Vrbský, J., Tereh, T., Kyrylenko, S., Dvořák, P., & Krejčí, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127739 · Cited by 10
Erase and Rewind: Epigenetic Conversion of Cell Fate
Pennarossa, G., Zenobi, A., Gandolfi, C. E., Manzoni, E. F. M., Gandolfi, F., & Brevini, T. A. L. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9637-1 · Cited by 10
Yang, J., Kaur, K., Edwards, J. G., Eisenberg, C. A., & Eisenberg, L. M. (2017) · Stem Cells International · doi:10.1155/2017/3464953 · Cited by 10
Atkinson-Dell, R., & Mohamet, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_15 · Cited by 10
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10672-5 · Cited by 9
“Almost at the same time that iPSCs were presented, small molecules were used as an alternative approach to induce iPSCs because of their convenience and less controversy in the biosecurity of application [117–119].”
Recent advances of physiochemical cues on surfaces for directing cell fates
Deng, W., Yang, X., Yu, J., Omari‐Siaw, E., & Xu, X. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114550 · Cited by 9
Wu, Q., Gan, M., Ma, J., Zhang, H., Niu, L., Zhao, Y., Chen, L., Wang, Y., Zhang, S., Zhu, L., et al. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.10.007 · Cited by 9
Self-citationTherapeutic potential of astrocyte transdifferentiated neurons
Liang, X., Qin, R., Qin, Q., Xu, W., Xu, H., Lai, X., Shao, L., Li, C., Xie, M., Xiong, X., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00554 · Cited by 9
Lee, J., Han, M., Wang, K., Butler, L. R., & Sinclair, D. A. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101442 · Cited by 9
Selected small molecules as inductors of pluripotent stem cells
Baranek, M., Markiewicz, W. T., & Barciszewski, J. (2016) · Acta Biochimica Polonica · doi:10.18388/abp.2016_1363 · Cited by 9
Deciphering the decisive factors driving fate bifurcations in somatic cell reprogramming
Long, C., Li, H., Liang, P., Chao, L., Hong, Y., Zhang, J., Xi, Q., & Zuo, Y. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102044 · Cited by 9
Self-citationChang, D., Sun, C., Tian, X., Liu, H., Jia, Y., & Guo, Z. (2024) · FEBS Open Bio · doi:10.1002/2211-5463.13811 · Cited by 9
Customized Proteinaceous Nanoformulation for In Vivo Chemical Reprogramming
Chen, H., Xiang, J., Liu, Y., Pi, W., Zhang, H., Lu, W., Liu, Y., Ji, S., Li, Y., Cui, S., et al. (2024) · Advanced Materials · doi:10.1002/adma.202311845 · Cited by 9
Self-citationLiu, J., Ji, Z., He, Q., Chen, H., Xu, X., Mei, Q., Hu, Y., & Zhang, H. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106683 · Cited by 9
Roslan, F. F., Yu, Y., Ooi, G., Then, K., Then, K. Y., Cheong, S., Guo, Z., Patar, M. N. A. A., & Tan, J. J. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5438 · Cited by 9
Role and research progress of histone modification in cardiovascular diseases (Review)
Qi, Q., Li, L., Liang, H., & Zeng, Y. (2025) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2025.12882 · Cited by 9
Cell and Hydrogel‐Integrated Therapies for Intervertebral Disc Regeneration
Tang, Y., Lin, X., Som, A., & Zhang, M. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202502354 · Cited by 9
Li, L., Zhang, L., Liu, G., Feng, R., Jiang, Y., Yang, L., Zhang, S., Liao, M., & Hua, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105180 · Cited by 9
Hao, Q., An, J.-Q., Hao, F., Yang, C., Lu, T., Qu, T., Zhao, L.-R., & Duan, W.-M. (2015) · Cellular Reprogramming · doi:10.1089/cell.2015.0025 · Cited by 9
Goonoo, N., & Bhaw‐Luximon, A. (2018) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/jmr.2018.132 · Cited by 9
Li, L., Zhang, D., Ren, Y., Ye, S., Zheng, B., Liu, S., Ahmed, J. Z., Li, M., Shi, D., & Huang, B. (2018) · Reproduction in Domestic Animals · doi:10.1111/rda.13304 · Cited by 9
Ai, H., Qin, H., Li, J., Niu, C., Song, Z., Bao, Y., Sun, L., Zheng, L., & Li, Y. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113984 · Cited by 9
Self-citationBelviso, I., Romano, V., Nurzyńska, D., Castaldo, C., & Meglio, F. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.95070 · Cited by 9
Current Knowledge on Stem Cells in Ascidians
Vanni, V., Anselmi, C., Ballarin, L., Drago, L., Gasparini, F., Gordon, T., Peronato, A., Rosental, B., Rosner, A., Rinkevich, B., et al. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-1635-6-9 · Cited by 10
Quan, Y., Wang, M., Xu, C., Wang, X., Wu, Y., Qin, D., Lin, Y., Lu, X., Lu, F., & Li, L. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac236 · Cited by 9
Chemical Pretreatment Activated a Plastic State Amenable to Direct Lineage Reprogramming
Yang, Z., Xu, X., Gu, C., Nielsen, A. V., Chen, G., Guo, F., Tang, C., & Zhao, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.865038 · Cited by 9
Self-citationLi, Z., Li, Y., Zhang, Q., Ge, W., Zhang, Y., Zhao, X., Hu, J., Yuan, L., & Zhang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031917 · Cited by 9
Self-citationWYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα
Qian, Z., Lin, W., Cai, X., Wu, J., Ke, K., Ye, Z., & Wu, F. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2023.2299288 · Cited by 9
Antón‐Fernández, A., Cuadros, R., Peinado-Cahuchola, R., Hernández, F., & Ávila, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-57095-x · Cited by 9
Impact of surgical innovation on tissue repair in the surgical patient
Tevlin, R., Atashroo, D. A., Duscher, D., McArdle, A., Gurtner, G. C., Wan, D. C., & Longaker, M. T. (2015) · British journal of surgery · doi:10.1002/bjs.9672 · Cited by 9
Giri, S., & Bader, A. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.08.001 · Cited by 9
Conversion of non-adipogenic fibroblasts into adipocytes by a defined hormone mixture
Nie, T., Hui, X. H., Gao, X., Nie, B., Mao, L., Tang, X., Yuan, R., Li, K., Li, P., Xu, A., et al. (2015) · Biochemical Journal · doi:10.1042/bj20140727 · Cited by 9
Plasticity of spermatogonial stem cells
Cooke, P. S., Simon, L., Nanjappa, M. K., Medrano, T. I., & Berry, S. E. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.148072 · Cited by 9
Uno, N., Uno, K., Komoto, S., Suzuki, T., Hiratsuka, M., Osaki, M., Kazuki, Y., & Oshimura, M. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.45 · Cited by 9
Sani, M. R. M., & Ghahfarrokhi, A. M. (2017) · Journal of Otology · doi:10.1016/j.joto.2017.03.003 · Cited by 9
Gibson, G. E., & Thakkar, A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.06.007 · Cited by 9
Human-Derived Neurons and Neural Progenitor Cells in High Content Imaging Applications
Harrill, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7357-6_18 · Cited by 9
Screening-Based Chemical Approaches to Unravel Stem Cell Biology
Chen, S. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.11.012 · Cited by 9
Ge, J.-Y., Zheng, Y., Liu, L., Isoda, H., & Oda, T. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i9.650 · Cited by 9
Self-citationReprogramming of Fibroblasts to Human iPSCs by CRISPR Activators
Weltner, J., & Trokovic, R. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1084-8_12 · Cited by 9
Therapeutic effects and perspective of stem cell extracellular vesicles in aging and cancer
Liu, Y., Cheng, Y., Wang, S., Su, Y., Liu, Y., Li, C., Jin, L., Wan, Q., Sang, X., & Wang, Z. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30212 · Cited by 9
Aguirre-Vázquez, A., Salazar‐Olivo, L. A., Flores-Ponce, X., Arriaga-Guerrero, A. L., Garza-Rodríguez, D., Camacho-Moll, M. E., Velasco, I., Castorena‐Torres, F., Dadheech, N., & de León, M. B. (2021) · Molecules · doi:10.3390/molecules26071909 · Cited by 9
Induced pluripotent stem (iPS) cells from human fetal stem cells
Guillot, P. V. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.08.007 · Cited by 9
Cellular reprogramming by transcription factor engineering
Tsang, J. C. H., Gao, X., Lu, L., & Liu, P. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.07.001 · Cited by 9
Efficient derivation of extended pluripotent stem cells from NOD-scid Il2rg−/− mice
Du, Y., Wang, T., Xu, J., Zhao, C., Li, H., Fu, Y., Xu, Y., Xie, L., Zhao, J., Yang, W., et al. (2018) · Protein & Cell · doi:10.1007/s13238-018-0558-z · Cited by 9
Self-citationConnexins in the development and physiology of stem cells
Ngezahayo, A., & Ruhe, F. (2021) · Tissue Barriers · doi:10.1080/21688370.2021.1949242 · Cited by 9
Prospective applications of induced pluripotent stem cells in military medicine
Saha, B., Kumar, H. K., Borgohain, M. P., & Thummer, R. P. (2018) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2018.03.005 · Cited by 9
Flavonoid scutellarin positively regulates root length through NUTCRACKER
Huang, X., Li, W., & Zhang, X. (2020) · Acta Botanica Yunnanica · doi:10.1016/j.pld.2020.08.001 · Cited by 9
Self-citationLi, J., Chen, L.-T., Wang, Y.-L., Kang, M.-X., Liang, S., Hong, X., Hou, F. F., & Zhang, F. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01445-y · Cited by 8
Development of a next-generation endogenous OCT4 inducer and its anti-aging effect in vivo
Kang, H. C., Hasselbeck, S., Taškova, K., Wang, N., van Oosten, L. N., Mrowka, R., Utikal, J. S., Andrade-Navarro, M. A., Wang, J., Wölfl, S., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115513 · Cited by 8
Derivation and application of pluripotent stem cells for regenerative medicine
Wang, J., & Zhou, Q. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-5066-x · Cited by 8
Yi, B., Dissanayaka, W. L., & Zhang, C. (2020) · Journal of Endodontics · doi:10.1016/j.joen.2020.06.024 · Cited by 8
Zviran, A., & Hanna, J. H. (2014) · Genome biology · doi:10.1186/gb4167 · Cited by 8
Edwards, N., McCaughey‐Chapman, A., Combrinck, C., Geiger, J. P., & Connor, B. J. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0130 · Cited by 8
Wu, Y., Zhang, Z., Wu, S., Chen, Z., & Pu, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-43798-0 · Cited by 8
Progress, problems and prospects of porcine pluripotent stem cells
WANG, Y. P. H., Pei, Y., Ning, L. I., & Jianyong, H. A. N. (2014) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2014009 · Cited by 8
Wegener, M., Bader, A., & Giri, S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.02.010 · Cited by 8
Control of the hematopoietic stem cell state
Knapp, D. J. H. F., & Eaves, C. J. (2013) · Cell Research · doi:10.1038/cr.2013.139 · Cited by 8
The triumph of chemically enhanced cellular reprogramming: a patent review
Anwar, M. A., Kim, S., & Choi, S. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1118058 · Cited by 8
Moratilla, A., de la Maza, D. S., Martin, M. C., López-Iglesias, P., González-Peramato, P., & Miguel, M. P. D. (2015) · PubMed · Cited by 8
Sun, W.-S., Chun, J.-L., Tae, J., Kim, D., Ahn, J. S., Kim, M. K., Hwang, I., Kwon, D., Hwang, S., & Lee, J.-W. (2016) · Stem Cells International · doi:10.1155/2016/1390284 · Cited by 8
Chemical screen for epigenetic barriers to single allele activation of Oct4
Headley, K. M., Kedziora, K. M., Alejo, A., Lai, E. Z.-X., Purvis, J. E., & Hathaway, N. A. (2019) · Stem Cell Research · doi:10.1016/j.scr.2019.101470 · Cited by 8
Rawat, N., & Singh, M. K. (2017) · Veterinary World · doi:10.14202/vetworld.2017.640-649 · Cited by 8
Culture bovine prospermatogonia with 2i medium
Cai, H., Jiang, Y., Zhang, S., Cai, N., Zhu, W., Yang, R., Tang, B., Li, Z., & Zhang, X. (2021) · Andrologia · doi:10.1111/and.14056 · Cited by 8
Self-citationA Small-Molecule Cocktails-Based Strategy in Culture of Mesenchymal Stem Cells
Feng, Y., Luo, J., Cheng, J., Xu, A., Qiu, D., He, S., Zheng, D., Jia, C., Zhang, Q., & Lin, N. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.819148 · Cited by 8
Self-citationEfficient derivation of embryonic stem cells from NOD-scid Il2rg −/− mice
Liu, K., Fang, R., Li, H., Yang, W., Miao, Z., Wen, J., & Deng, H. (2015) · Protein & Cell · doi:10.1007/s13238-015-0209-6 · Cited by 8
Self-citationDing, Q., & Cowan, C. A. (2013) · Cell Research · doi:10.1038/cr.2013.117 · Cited by 8
Reprogramming Somatic Cells to a Kidney Fate
Takasato, M., Vanslambrouck, J. M., & Little, M. H. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.06.012 · Cited by 8
Generation of Fully Pluripotent Female Murine-Induced Pluripotent Stem Cells1
Di, K., Gao, S., Cui, L.-F., Chang, G., Wu, F., Ren, L., An, L., Miao, K., Tan, K., Tao, L., et al. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.114.124958 · Cited by 8
New iPSC for old long QT syndrome modeling: Putting the evidence into perspective
Li, G., Cheng, G., Wu, J., Ma, S., & Sun, C. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213514000 · Cited by 8
Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy
Panda, A., Gurusamy, N., Rajasingh, S., Carter, H.-K., Thomas, E. L., & Rajasingh, J. (2020) · Differentiation · doi:10.1016/j.diff.2019.12.001 · Cited by 8
Li, X., Zhang, P., Jiang, S., Ding, B., Zuo, X., Li, Y., Cao, Z., & Zhang, Y. (2017) · Animal Science Journal · doi:10.1111/asj.12871 · Cited by 8
Self-citationCapturing and Interconverting Embryonic Cell Fates in a Dish
Watts, J. L., Lokken, A. A., Moauro, A., & Ralston, A. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.11.008 · Cited by 8
Making cardiomyocytes with your chemistry set: Small molecule-induced cardiogenesis in somatic cells
Kim, W., Jung, D., & Williams, D. R. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i3.125 · Cited by 8
Metadata
- Authors
- Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., & Deng, H.
- Affiliations
- Peking University (CN)
- Beijing Vitalstar Biotechnology Co., Ltd., Beijing 100012, China.
- Corresponding author
- Hou, Pingping
- Li, Yanqin
- Zhang, Xu
- Liu, Chun
- Guan, Jingyang
- Li, Honggang
- Zhao, Ting
- Ye, Junqing
- Yang, Weifeng
- Liu, Kang
- Ge, Jian
- Xu, Jun
- Zhang, Qiang
- Zhao, Yang
- Deng, Hongkui
- ORCID
- Venue
- Science
- Published
- 2013-08-09
- Volume
- 341
- Issue
- 6146
- Pages
- 651-654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2101569447
- Cited by
- 1,402
- References
- 38
- Citations by year
- 2026: 51 · 2025: 76 · 2024: 78 · 2023: 77 · 2022: 72 · 2021: 85 · 2020: 84 · 2019: 84 · 2018: 114 · 2017: 114 · 2016: 161 · 2015: 165 · 2014: 182 · 2013: 59
- FWCI
- 84.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Microsoft Research
- York University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- pluripotent stem cells, chemical reprogramming, small molecules, somatic cell reprogramming, induced pluripotent stem cells, germline transmission, epigenetic status, differentiation potential, master genes
- MeSH terms
- Animals, Fibroblasts, Mice, Inbred C57BL, Mice, Inbred ICR, Promoter Regions, Genetic, Cadherins, Gene Expression Profiling, Green Fluorescent Proteins, Octamer Transcription Factor-3, Mice, Small Molecule Libraries, Induced Pluripotent Stem Cells, Epithelial-Mesenchymal Transition, Cell Engineering, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.